Search company, investor...

Predict your next investment

Diversified Financial Services
oriza.com.cn

Investments

324

Portfolio Exits

55

Funds

20

About Oriza Holdings

Oriza Holdings is a diversified financial service company that is engaged in businesses of equity investments, debt financing as well as equity investment-related services. Its venture capital arm, Oriza Equity Investment is actively involved in investments of TMT, healthcare, smart hardware, internet and semi-conductor sectors.

Headquarters Location

Building 19, Dongsha Lake Equity Investment Center Suhong East Road No.183, Suzhou Industry Park

Suzhou, Jiangsu,

China

86-512-6696-9999

Want to inform investors similar to Oriza Holdings about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Oriza Holdings News

Eluminex Biosciences Closes $40+ M Series B Financing

Feb 28, 2023

Eluminex Biosciences , a Suzhou, China and San Francisco, CA-based biotechnology company focusing on ophthalmic diseases and recombinant human collagen technology, raised $40+ M in Series B funding. The round was led by Cenova Capital with participation from Guangzhou Yuexiu Industrial Investment Fund Management, 3E Bioventures Capital, Oriza Holdings, and Series A investors. The company intends to use the funds to expand its development efforts. Founded in February 2020 and led by Dr. Jinzhong Zhang, Founder, Chairman and CEO, Eluminex is a clinical-stage biotechnology company dedicated to the research and development of global innovative therapeutics with a focus on ophthalmology and recombinant human collagen technology. Eluminex’ pipeline programs include novel multi-targeted antibody molecules for vision-threatening retinal diseases, an oral small molecule for rare inherited pediatric retinal dystrophies, and the clinical development and manufacturing of recombinant human collagen-based products with the potential to be world’s first biosynthetic cornea for the treatment of corneal stromal blinding diseases. The company is currently building a GMP facility in BioBAY of Suzhou Industrial Park for the manufacturing of the recombinant human collagen biosynthetic cornea and other collagen-based products and is expected to operate in mid-2023. Eluminex also has a clinical and registration center located in South San Francisco, California. FinSMEs 28/02/2023

Oriza Holdings Investments

324 Investments

Oriza Holdings has made 324 investments. Their latest investment was in Sequential Technology as part of their Series A - II on May 5, 2023.

CBI Logo

Oriza Holdings Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/9/2023

Series A - II

Sequential Technology

Yes

3

5/8/2023

Series A

Eco EV

Yes

1

4/3/2023

Series A - III

Muchuang

Yes

4

3/31/2023

Series B - II

Subscribe to see more

Subscribe to see more

10

3/30/2023

Series B

Subscribe to see more

Subscribe to see more

10

Date

5/9/2023

5/8/2023

4/3/2023

3/31/2023

3/30/2023

Round

Series A - II

Series A

Series A - III

Series B - II

Series B

Company

Sequential Technology

Eco EV

Muchuang

Subscribe to see more

Subscribe to see more

Amount

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

1

4

10

10

Oriza Holdings Portfolio Exits

55 Portfolio Exits

Oriza Holdings has 55 portfolio exits. Their latest portfolio exit was Maxic Technology on May 22, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/22/2023

IPO

$99M

Public

2

4/24/2023

IPO

$99M

Public

1

4/7/2023

IPO

$99M

Public

1

2/10/2023

IPO

Subscribe to see more

$99M

Subscribe to see more

10

11/16/2022

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/22/2023

4/24/2023

4/7/2023

2/10/2023

11/16/2022

Exit

IPO

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Public

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

Oriza Holdings Acquisitions

2 Acquisitions

Oriza Holdings acquired 2 companies. Their latest acquisition was Synaptics - LCD TDDI Business on December 24, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/24/2019

$99M

Acquired Unit

3

3/18/2010

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/24/2019

3/18/2010

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Acquired Unit

Subscribe to see more

Sources

3

10

Oriza Holdings Fund History

20 Fund Histories

Oriza Holdings has 20 funds, including SIP Oriza Zhengze No. 1 Fund LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2013

SIP Oriza Zhengze No. 1 Fund LP

Early-Stage Venture Capital

Closed

$81.97M

1

6/8/2011

Guochuang Yuanhe Fund of Funds

Fund Of Funds

Open

$771.38M

1

6/30/2009

Infinity Israel-China Fund

Expansions & Growth

Closed

$350M

1

12/4/2008

Kaifeng Fund

Subscribe to see more

Subscribe to see more

$99M

10

3/1/2008

Yuandian Venture Capital

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/31/2013

6/8/2011

6/30/2009

12/4/2008

3/1/2008

Fund

SIP Oriza Zhengze No. 1 Fund LP

Guochuang Yuanhe Fund of Funds

Infinity Israel-China Fund

Kaifeng Fund

Yuandian Venture Capital

Fund Type

Early-Stage Venture Capital

Fund Of Funds

Expansions & Growth

Subscribe to see more

Subscribe to see more

Status

Closed

Open

Closed

Subscribe to see more

Subscribe to see more

Amount

$81.97M

$771.38M

$350M

$99M

$99M

Sources

1

1

1

10

10

Oriza Holdings Team

3 Team Members

Oriza Holdings has 3 team members, including current President, Xianghong Lin.

Name

Work History

Title

Status

Xianghong Lin

President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Xianghong Lin

Subscribe to see more

Subscribe to see more

Work History

Title

President

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.